about
Beta-thalassemiaReducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectivesBisphosphonate therapy in pediatric patientsPregnancy in women with thalassemia: challenges and solutionsPrevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in patients with thalassemia major in Iran: A meta-analysis study.Osteoporosis syndrome in thalassaemia major: an overview.Anemia and growthThalassaemia and aberrations of growth and puberty.National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage aPrevalence of endocrinopathies in patients with Beta-thalassaemia major - a cross-sectional study in oman.Acquired Hypogonadotropic Hypogonadism (AHH) in Thalassaemia Major Patients: An Underdiagnosed Condition?The thalassaemia syndromes.Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia.Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelinesIron Overload : A Cause of Primary AmenorrheaRegional consensus opinion for the management of Beta thalassemia major in the Arabian Gulf areaGrowth and endocrine function in thalassemia major in childhood and adolescence.Alternative options for DNA-based experimental therapy of β-thalassemia.Thalassaemia in children: from quality of care to quality of life.β-thalassemia patients and gynecological approach: review and clinical experience.Failure of puberty in Egyptian beta thalassemic patients: experience in north east region - Dakahlia province.Hypogonadism in thalassemia major patients.The impact of genotype on endocrine complications in thalassaemia major.Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia.Risk factors associated with hypogonadism in β-thalassemia major patients: predictors for a frequent complication of a rare disease.Gonadal function of young patients with beta-thalassemia following bone marrow transplantation.Pituitary iron and volume imaging in healthy controls.Final height in short polytransfused thalassemia major patients treated with recombinant growth hormone.Quantitative T2* magnetic resonance imaging for evaluation of iron deposition in the brain of β-thalassemia patients.Iron overload detection using pituitary and hepatic MRI in thalassemic patients having short stature and hypogonadism.Gonadal dysfunction and pelvic sonographic findings in females with thalassaemia major.Joint diabetes thalassaemia clinic: an effective new model of care.Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future ExpectationsLate effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience.
P2860
Q21202886-6454D2D5-DB39-4F55-8568-0CE168671D12Q26740347-E3A1EF90-C19D-4E64-802B-F7D249BFF2AAQ26830702-C14E585C-7804-4F93-A1DE-904488D6D07FQ28080216-7C152045-090A-4552-BF76-CD419C689C67Q33624121-1FC6C4DF-0141-4106-81BB-DD66A4FE1AE2Q34211460-414CC4F6-0BA3-4848-AC78-26CDB67D2EE2Q34455551-849ED9D6-0ABC-4AD4-B0FA-B2D9B9CC93F1Q34549388-2DEF4428-EC6A-428D-90EB-11758B6C3A3CQ35549037-C4B9CC48-ECF5-4EB2-BB51-7D67E5767210Q35740873-A6763A6C-73BB-4F23-B029-85E10D264472Q36417579-22BFF4EC-D129-440C-A941-CE630DB6D501Q36762089-2C3EC99F-F177-4EE9-9AB3-3715E55A8590Q36817996-347E299C-2AC8-48CE-8675-0235F8C42F01Q36862278-7C793FC7-95DD-435E-B5CF-F77E266613D0Q37037134-F7394878-339F-4560-A347-279D86CE6A87Q37359617-12E95A73-8A08-474F-BB84-71096E7C26D7Q37702771-465A8D26-F5B3-4C06-856A-BA77EB0724CFQ37993118-BEF9DFAF-3057-4B00-B25C-9D8F69CA2A3DQ38569638-8BE1BB6D-820E-4F3D-AE9A-E0B14544E34EQ38613976-E5B377CF-7E48-44BB-9B5E-6734900AD66CQ38855960-98066273-9F7C-49CE-B9AE-269AD3F09205Q42688838-25439B4E-09C3-407A-B1E3-46164D8B6617Q44806483-1A642DC4-4EAA-4EC3-8320-E4E996FB0745Q45227560-80380759-419D-4AFE-8BEB-71D0251A00AAQ45888439-55B07496-68EF-4301-AB73-75F92281E98FQ46152924-7C203C52-45A0-4C8D-A288-938236612AB3Q46514360-F5FD11C4-E980-426D-9F57-B679BC9B87B1Q46781383-1FBD6BF8-6B5D-445D-A4D2-AA046716724FQ47377858-971E0838-9BAF-4E9C-9D76-813ECBF0892BQ48787004-2C25C135-E905-45C7-9168-D6DECD27AB73Q49056653-62123714-82A1-4A0C-A65F-857972898DC7Q51597087-F68428EB-0711-45F9-BC83-0F10C31E89B9Q54421844-0A28DEFE-4046-4AFC-BB35-E0ACBEFDE0E1Q54585888-16B7727D-7AD3-49A8-8153-37E67EA6AE36Q55638215-45F9C44E-65C1-42B2-B94A-F248B96C5A18
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Growth and puberty and its management in thalassaemia.
@ast
Growth and puberty and its management in thalassaemia.
@en
type
label
Growth and puberty and its management in thalassaemia.
@ast
Growth and puberty and its management in thalassaemia.
@en
prefLabel
Growth and puberty and its management in thalassaemia.
@ast
Growth and puberty and its management in thalassaemia.
@en
P356
P1433
P1476
Growth and puberty and its management in thalassaemia.
@en
P2093
De Sanctis V
P356
10.1159/000064766
P478
58 Suppl 1
P577
2002-01-01T00:00:00Z